MeSH Review:
Stomach Neoplasms
Stefania Boccia,
Gualtiero Ricciardi,
Angelo De Lauretis,
Cornelia M. van Duijn,
Francesco Gianfagna,
Huntsman,
Maung,
Monaghan,
Hayashi,
Seruca,
Carneiro,
MacLeod,
Jackson,
Lewis,
Caldas,
Silberg,
Sackett,
Kang,
Swain,
Kaestner,
Sund,
Sullivan,
Moffett,
Varro,
Hemers,
Dockray,
Archer,
Haigh,
Dimaline,
Pagliocca,
Ahmed,
Ott,
Fink,
Stahl,
Schwaiger,
Stein,
Siewert,
Becker,
Link,
Weber,
Dittler,
Lordick,
Busch,
El-Omar,
Vaughan,
Stanford,
Goedert,
Rabkin,
Chow,
Fraumeni,
Schoenberg,
Blot,
Gammon,
Risch,
Mayne,
Maeda,
Yamaji,
Omata,
Hirata,
Shiratori,
Mitsuno,
Akanuma,
Yoshida,
Ogura,
- External imaging of gastric-cancer metastases with radiolabelled CEA and CSAp antibodies. Nelson, M.O., DeLand, F.H., Shocat, D., Bennett, S.J., Goldenberg, D.M. N. Engl. J. Med. (1983)
- p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S.L., Galle, P.R., Stremmel, W., Oren, M., Krammer, P.H. J. Exp. Med. (1998)
- Gastrin protection against chemically induced gastric adenocarcinomas in Wistar rats: histopathology of the glandular stomach and incidence of gastric adenocarcinoma. Tatsuta, M., Yamamura, H., Taniguchi, H., Tamura, H. J. Natl. Cancer Inst. (1982)
- Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Huang, J.Q., Zheng, G.F., Sumanac, K., Irvine, E.J., Hunt, R.H. Gastroenterology (2003)
- p53 gene mutations in gastric and esophageal cancers. Imazeki, F., Omata, M., Nose, H., Ohto, M., Isono, K. Gastroenterology (1992)
- Methylenetetrahydrofolate reductase 677C>T polymorphism and gastric cancer susceptibility in Mexico. Lacasaña-Navarro, M., Galván-Portillo, M., Chen, J., López-Cervantes, M., López-Carrillo, L. Eur. J. Cancer (2006)
- Gastric carcinogenesis: diet as a causative factor. Sugimura, T., Wakabayashi, K. Medical oncology and tumor pharmacotherapy. (1990)
- Mortality at ages 75 and older in the Cancer Prevention Study (CPS I). Lew, E.A., Garfinkel, L. CA: a cancer journal for clinicians. (1990)
- Causal relationship between the loss of RUNX3 expression and gastric cancer. Li, Q.L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K., Chi, X.Z., Lee, K.Y., Nomura, S., Lee, C.W., Han, S.B., Kim, H.M., Kim, W.J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, A., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S.C., Ito, Y. Cell (2002)
- Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. Huntsman, D.G., Carneiro, F., Lewis, F.R., MacLeod, P.M., Hayashi, A., Monaghan, K.G., Maung, R., Seruca, R., Jackson, C.E., Caldas, C. N. Engl. J. Med. (2001)
- Mortality among workers exposed to ethylene oxide. Steenland, K., Stayner, L., Greife, A., Halperin, W., Hayes, R., Hornung, R., Nowlin, S. N. Engl. J. Med. (1991)
- Nitrate and gastric cancer risks. Tannenbaum, S.R., Correa, P. Nature (1985)
- Gastric cancer and salivary nitrate and nitrite. Mirvish, S.S. Nature (1985)
- Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Liu, S.Q., Saijo, K., Todoroki, T., Ohno, T. Nat. Med. (1995)
- High concentrations of glutathione in glandular stomach: possible implications for carcinogenesis. Body, S.C., Sasame, H.A., Body, M.R. Science (1979)
- Gastric cancer: current status of treatment. Carter, S.K., Comis, R.L. J. Natl. Cancer Inst. (1977)
- Ramucirumab: successfully targeting angiogenesis in gastric cancer. Javle, M., Smyth, E.C., Chau, I. Clin. Cancer Res. (2014)
- Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Grady, W.M., Willis, J., Guilford, P.J., Dunbier, A.K., Toro, T.T., Lynch, H., Wiesner, G., Ferguson, K., Eng, C., Park, J.G., Kim, S.J., Markowitz, S. Nat. Genet. (2000)
- Diet and chronic atrophic gastritis: a case-control study. Fontham, E., Zavala, D., Correa, P., Rodriguez, E., Hunter, F., Haenszel, W., Tannenbaum, S.R. J. Natl. Cancer Inst. (1986)
- Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. El-Omar, E.M., Rabkin, C.S., Gammon, M.D., Vaughan, T.L., Risch, H.A., Schoenberg, J.B., Stanford, J.L., Mayne, S.T., Goedert, J., Blot, W.J., Fraumeni, J.F., Chow, W.H. Gastroenterology (2003)
- Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Silberg, D.G., Sullivan, J., Kang, E., Swain, G.P., Moffett, J., Sund, N.J., Sackett, S.D., Kaestner, K.H. Gastroenterology (2002)
- Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: Role of Rho GTPase and menin. Varro, A., Hemers, E., Archer, D., Pagliocca, A., Haigh, C., Ahmed, S., Dimaline, R., Dockray, G.J. Gastroenterology (2002)
- Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. Monakhov, N.K., Neistadt, E.L., Shavlovskil, M.M., Shvartsman, A.L., Neĭfakh, S.A. J. Natl. Cancer Inst. (1978)
- Protein synthesis in hepatocytes isolated from patients with gastrointestinal malignancy. Starnes, H.F., Warren, R.S., Brennan, M.F. J. Clin. Invest. (1987)
- Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Ishige, I., Usui, Y., Takemura, T., Eishi, Y. Lancet (1999)
- Gastric-juice nitrite and gastric cancer. Jones, S.M., Davies, P.W., Savage, A. Lancet (1978)
- Cyclooxygenase-2 inhibitor (SC-236) suppresses activator protein-1 through c-Jun NH2-terminal kinase. Wong, B.C., Jiang, X.H., Lin, M.C., Tu, S.P., Cui, J.T., Jiang, S.H., Wong, W.M., Yuen, M.F., Lam, S.K., Kung, H.F. Gastroenterology (2004)
- Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Iwase, K., Evers, B.M., Hellmich, M.R., Guo, Y.S., Higashide, S., Kim, H.J., Townsend, C.M. Gastroenterology (1997)
- The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. Tanida, S., Joh, T., Itoh, K., Kataoka, H., Sasaki, M., Ohara, H., Nakazawa, T., Nomura, T., Kinugasa, Y., Ohmoto, H., Ishiguro, H., Yoshino, K., Higashiyama, S., Itoh, M. Gastroenterology (2004)
- Somatic mutations of the trefoil factor family 1 gene in gastric cancer. Park, W.S., Oh, R.R., Park, J.Y., Lee, J.H., Shin, M.S., Kim, H.S., Lee, H.K., Kim, Y.S., Kim, S.Y., Lee, S.H., Yoo, N.J., Lee, J.Y. Gastroenterology (2000)
- H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Maeda, S., Yoshida, H., Ogura, K., Mitsuno, Y., Hirata, Y., Yamaji, Y., Akanuma, M., Shiratori, Y., Omata, M. Gastroenterology (2000)
- Polymorphisms of MTHFD, plasma homocysteine levels, and risk of gastric cancer in a high-risk Chinese population. Wang, L., Ke, Q., Chen, W., Wang, J., Tan, Y., Zhou, Y., Hua, Z., Ding, W., Niu, J., Shen, J., Zhang, Z., Wang, X., Xu, Y., Shen, H. Clin. Cancer Res. (2007)
- CYP2E1PstI/RsaI polymorphism and interaction with tobacco, alcohol and GSTs in gastric cancer susceptibility: A meta-analysis of the literature. Boccia, S., De Lauretis, A., Gianfagna, F., van Duijn, C.M., Ricciardi, G. Carcinogenesis (2007)
- Genetic alterations of the ATBF1 gene in gastric cancer. Cho, Y.G., Song, J.H., Kim, C.J., Lee, Y.S., Kim, S.Y., Nam, S.W., Lee, J.Y., Park, W.S. Clin. Cancer Res. (2007)
- Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells. Chochi, K., Ichikura, T., Kinoshita, M., Majima, T., Shinomiya, N., Tsujimoto, H., Kawabata, T., Sugasawa, H., Ono, S., Seki, S., Mochizuki, H. Clin. Cancer Res. (2008)
- Reprimo as a potential biomarker for early detection in gastric cancer. Bernal, C., Aguayo, F., Villarroel, C., Vargas, M., Díaz, I., Ossandon, F.J., Santibáñez, E., Palma, M., Aravena, E., Barrientos, C., Corvalan, A.H. Clin. Cancer Res. (2008)
- Clinical Significance of miR-146a in Gastric Cancer Cases. Kogo, R., Mimori, K., Tanaka, F., Komune, S., Mori, M. Clin. Cancer Res. (2011)
- Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Katz, J.P., Perreault, N., Goldstein, B.G., Actman, L., McNally, S.R., Silberg, D.G., Furth, E.E., Kaestner, K.H. Gastroenterology (2005)
- Histamine-2-receptor antagonists and gastric cancer risk. La Vecchia, C., Negri, E., D'Avanzo, B., Franceschi, S. Lancet (1990)
- 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. MacDonald, J.S., Schein, P.S., Woolley, P.V., Smythe, T., Ueno, W., Hoth, D., Smith, F., Boiron, M., Gisselbrecht, C., Brunet, R., Lagarde, C. Ann. Intern. Med. (1980)
- Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.J., Busch, R., Stein, H., Lordick, F., Link, T., Schwaiger, M., Siewert, J.R., Weber, W.A. J. Clin. Oncol. (2003)